Učitavanje...

Identification of novel therapeutic targets in the PI3K/AKT/mTOR pathway in hepatocellular carcinoma using targeted next generation sequencing

Understanding genetic aberrations in cancer leads to discovery of new targets for cancer therapies. The genomic landscape of hepatocellular carcinoma (HCC) has not been fully described. Therefore, patients with refractory advanced/metastatic HCC referred for experimental therapies, who had adequate...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Janku, Filip, Kaseb, Ahmed O., Tsimberidou, Apostolia M., Wolff, Robert A., Kurzrock, Razelle
Format: Artigo
Jezik:Inglês
Izdano: Impact Journals LLC 2014
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4102787/
https://ncbi.nlm.nih.gov/pubmed/24931142
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!